Literature DB >> 11727844

Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis.

F Silveri1, R De Angelis, A Poggi, S Muti, G Bonapace, F Argentati, C Cervini.   

Abstract

OBJECTIVE: To evaluate the relative roles of endothelium and platelets in the pathogenesis of primary RP and RP secondary to SSc.
METHODS: Endothelial derived ET-1, t-PA, PAI-1, and platelet derived beta-TG, PDGF, TGF-beta were measured in 36 patients with primary RP, 14 patients with RP secondary to SSc and 30 age and sex matched controls.
RESULTS: A significative increase of ET-1, t-PA, PAI-1, TGF-beta, and beta-TG were the most relevant changes in patients with RP secondary to SSc with respect to the controls. Less relevant increases of t-PA, PAI-1, PDGF, and beta-TG levels were observed in patients with primary RP vs controls.
CONCLUSIONS: These data seem to confirm the involvement of endothelial cells and platelets in the pathogenesis of RP, with mild changes in primary RP and more relevant changes in RP secondary to SSc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727844     DOI: 10.1080/030097401753180372

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  12 in total

1.  Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.

Authors:  Serdar Soydinc; Ibrahim Halil Turkbeyler; Yavuz Pehlivan; Gulcimen Soylu; Mehmet Fatih Goktepe; Muhammed Bilici; Orhan Zengin; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  A Randomized Controlled Trial of Acupressure for the Treatment of Raynaud's Phenomenon: The difficulty of conducting a trial in Raynaud's phenomenon.

Authors:  Heather Gladue; Veronica Berrocal; Richard Harris; Pei-Suen Tsou; Gautam Edhayan; Ray Ohara; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-05-02

Review 3.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  The role of platelets in the pathogenesis of systemic sclerosis.

Authors:  Giuseppe A Ramirez; Stefano Franchini; Patrizia Rovere-Querini; Maria Grazia Sabbadini; Angelo A Manfredi; Norma Maugeri
Journal:  Front Immunol       Date:  2012-06-18       Impact factor: 7.561

Review 5.  Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy.

Authors:  Anna Kuryliszyn-Moskal; Jacek Kita; Anna Hryniewicz
Journal:  Reumatologia       Date:  2015-05-18

Review 6.  From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders.

Authors:  Zuzanna Małgorzata Łukasik; Marcin Makowski; Joanna Samanta Makowska
Journal:  Rheumatol Int       Date:  2018-02-28       Impact factor: 2.631

7.  Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura.

Authors:  S Fessatou; P Nicolaidou; D Gourgiotis; H Georgouli; K Douros; M Moustaki; A Fretzayas
Journal:  BMC Pediatr       Date:  2008-09-02       Impact factor: 2.125

8.  A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation.

Authors:  Lorenzo Beretta; Marta Cossu; Maurizio Marchini; Francesca Cappiello; Andrea Artoni; Giovanna Motta; Raffaella Scorza
Journal:  Arthritis Res Ther       Date:  2008-09-01       Impact factor: 5.156

9.  Inhibition of angiogenesis by platelets in systemic sclerosis patients.

Authors:  Daniela Hirigoyen; Paula I Burgos; Veronica Mezzano; Josefina Duran; Magaly Barrientos; Claudia G Saez; Olga Panes; Diego Mezzano; Mirentxu Iruretagoyena
Journal:  Arthritis Res Ther       Date:  2015-11-19       Impact factor: 5.156

10.  Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolism.

Authors:  Joanna Żuk; Agnieszka Snarska-Drygalska; Krzysztof Piotr Malinowski; Elżbieta Papuga-Szela; Joanna Natorska; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.